These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. D-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new peroxisomal disorder with implications for other disorders of beta-oxidation. van Grunsven EG; van Berkel E; Denis S; Mooijer PA; Wanders RJ Adv Exp Med Biol; 1999; 466():365-9. PubMed ID: 10709664 [TBL] [Abstract][Full Text] [Related]
4. Complementation analysis of fibroblasts from peroxisomal fatty acid oxidation deficient patients shows high frequency of bifunctional enzyme deficiency plus intragenic complementation: unequivocal evidence for differential defects in the same enzyme protein. van Grunsven EG; van Roermund CW; Denis S; Wanders RJ Biochem Biophys Res Commun; 1997 Jun; 235(1):176-9. PubMed ID: 9196058 [TBL] [Abstract][Full Text] [Related]
5. Urinary bile acids and peroxisomal bifunctional enzyme deficiency. Natowicz MR; Evans JE; Kelley RI; Moser AB; Watkins PA; Moser HW Am J Med Genet; 1996 May; 63(2):356-62. PubMed ID: 8725785 [TBL] [Abstract][Full Text] [Related]
8. Biochemical findings in a series of Australian patients with isolated defects in peroxisomal beta-oxidation. Paton BC; Sharp PC; Poulos A Ann N Y Acad Sci; 1996 Dec; 804():750-1. PubMed ID: 8993614 [No Abstract] [Full Text] [Related]
11. Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ferdinandusse S; Denis S; Mooyer PA; Dekker C; Duran M; Soorani-Lunsing RJ; Boltshauser E; Macaya A; Gärtner J; Majoie CB; Barth PG; Wanders RJ; Poll-The BT Ann Neurol; 2006 Jan; 59(1):92-104. PubMed ID: 16278854 [TBL] [Abstract][Full Text] [Related]
12. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. Paton BC; Sharp PC; Crane DI; Poulos A J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223 [TBL] [Abstract][Full Text] [Related]
13. Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis. Wanders RJ; van Roermund CW; Brul S; Schutgens RB; Tager JM J Inherit Metab Dis; 1992; 15(3):385-8. PubMed ID: 1357231 [No Abstract] [Full Text] [Related]
15. Peroxisomal disorders: overview. Moser HW; Moser AB Ann N Y Acad Sci; 1996 Dec; 804():427-41. PubMed ID: 8993562 [No Abstract] [Full Text] [Related]
16. A bifunctional protein with deficient enzymic activity: identification of a new peroxisomal disorder using novel methods to measure the peroxisomal beta-oxidation enzyme activities. Wanders RJ; van Roermund CW; Schelen A; Schutgens RB; Tager JM; Stephenson JB; Clayton PT J Inherit Metab Dis; 1990; 13(3):375-9. PubMed ID: 2122104 [No Abstract] [Full Text] [Related]
17. Optico-cochleo-dentate degeneration associated with severe peripheral neuropathy and caused by peroxisomal D-bifunctional protein deficiency. Schröder JM; Hackel V; Wanders RJ; Göhlich-Ratmann G; Voit T Acta Neuropathol; 2004 Aug; 108(2):154-67. PubMed ID: 15235808 [TBL] [Abstract][Full Text] [Related]
18. A novel HPLC-based method to diagnose peroxisomal D-bifunctional protein enoyl-CoA hydratase deficiency. Gloerich J; Denis S; van Grunsven EG; Dacremont G; Wanders RJ; Ferdinandusse S J Lipid Res; 2003 Mar; 44(3):640-4. PubMed ID: 12562856 [TBL] [Abstract][Full Text] [Related]